Download PDFPDF
Clinical pharmacology
Triple antithrombotic management after stent implantation: when and how?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Response to Drs DeWilde and Ten Berg
    • Albert Schömig
    • Other Contributors:
      • Nikolaus Sarafoff, MD and Melchior Seyfarth, MD

    Randomised trials in patients on oral anticoagulation undergoing coronary stenting (response to Drs Willem Dewilde and Jurrien m ten Berg)

    Dear Sir,

    we agree with Dr. Dewilde and Dr. Ten Berg that current recommendations regarding coronary stenting in patients on oral anticoagulation (OAC) are not based on randomised controlled trials (RCT) and congratulate them for addressing this important issue by i...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Triple Therapie: proof or expert opinion?

    We read the article by Schömig et al (1) with great interest. We learned when and how physicians should prescribe triple antithrombotic therapy after stent implantation. Schömig states that further prospective clinical trials are needed in order to evaluate the best treatment strategy for patients on oral anticoagulant therapy (OAC) who undergo percutaneous coronary interventions (PCI). Unfortunately, all present recommendati...

    Show More
    Conflict of Interest:
    None declared.